Evidence map›Paper›PMID 39918768›Full record

ArticleCerebellum (London, England)2025

Novel Intermediate ATXN10 Alleles in the Healthy Peruvian Population: A Matter of Indigenous American Ethnic Origin.

Karina Milla-Neyra, Ismael Araujo-Aliaga, Carla Manrique-Enciso, Elison Sarapura-Castro, Maryenela Illanes-Manrique, Diego Veliz-Otani, Ana Saldarriaga-Mayo, Angel Medina-Colque, Julia Rios-Pinto, Ivan Cornejo-Herrera and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. NovelNeurology. Genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Karina Milla-Neyra *Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru. k.milla.neurogenetica@gmail.com.
Ismael Araujo-Aliaga *Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Carla Manrique-EncisoNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Elison Sarapura-CastroNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Maryenela Illanes-ManriqueNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Diego Veliz-OtaniNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Ana Saldarriaga-MayoNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Angel Medina-ColqueDirección Regional de Salud de Puno, Puno, Peru.
Julia Rios-PintoUniversidad Peruana Los Andes, Huancayo, Peru.
Ivan Cornejo-HerreraUniversidad Privada de Tacna, Tacna, Peru.
Andrea Rivera-ValdiviaNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Ignacio F MataGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Douglas LoeschInstitute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, MD, USA.
Leonel Lozano-VasquezNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Tanuja BordiaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Timothy O'ConnorInstitute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, MD, USA.
Birgitt SchüleDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Mario Cornejo-OlivasNeurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru. mcornejool@cientifica.edu.pe.

Funding

Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC-PROCIENCIA) Convention N°067-2020-01 (Contract N° 148-2020-FONDECYT)
6 · The paper itself

Abstract

Spinocerebellar ataxia type 10 (SCA10) is a neurodegenerative disease predominant in Latin American individuals with Indigenous American ancestry. SCA10 is caused by an expansion of ATTCT repeat within the ATXN10 gene. Healthy individuals carry 9-32 ATTCT repeats, whereas SCA10 patients carry an expansion of 280 repeats and higher. Recently, intermediate alleles (over than 32 repeats) have been identified in healthy Peruvian Indigenous American individuals, with unclear significance. This study aims to characterize the variability of the ATTCT repeats within the ATXN10 gene across self-declared Indigenous American and Mestizo subpopulations from Peru. A total of 871 samples (754 Mestizo and 117 Indigenous American) were analyzed using PCR, and RP-PCR when suspecting apparent homozygosity due to larger alleles. 8.7% of the total of healthy individuals (76/871) carry at least one intermediate allele. The 14-repeat allele being the most common for both subpopulations (41.5%). Intermediate alleles were detected in the Peruvian population (4.5%) with a significantly higher frequency among self-declared Indigenous American compared to Mestizo, suggesting a possible association with the ethnic origin. The G allele at the SNP rs41524547 had a frequency of 51.39% in individuals with intermediate alleles, with not significantly difference between subpopulations. Further analysis should be performed to confirm the size and composition of ATTCT repeat tract, as well as the contribution of rs41524547 in SCA10.

Indexed as

Ataxin-10Indians, South AmericanSpinocerebellar AtaxiasAdultAllelesDNA Repeat ExpansionEthnicityFemaleGene FrequencyHumansMalePeruAtaxin-10ATXN10 protein, humanAllelic distributionATXN10Indigenous AmericanRP-PCRSCA10

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.